Clinical trial
The Efficacy of Electrolysis Decontamination with or Without Leukocyteplatelet Rich Fibrin (L-PRF) in the Surgical Treatment of Peri-implantitis Defects: a Randomized Controlled Trial
NCT06614426 is registered in ClinicalTrials.gov with Abeer Hakam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Electrolysis Decontamination with or Without Leukocyteplatelet Rich Fibrin (L-PRF) in the Surgical Treatment of Peri-implantitis Defects: a Randomized Controlled Trial
- Lead sponsor
- Abeer Hakam
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2024
- Completion date
- December 30, 2026
- Enrollment
- 57 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
peri implantitis